Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Signes-Costa

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
American Journal of Respiratory Cell and Molecular Biology|February 27, 2023
Biomarkers of Fibrosis in Patients with COVID-19 One Year After Hospital Discharge: A Prospective Cohort StudyAlba Mulet, Julia Tarrasó, Enrique Rodríguez-Borja, et al.
Open Respiratory Archives|July 27, 2023
[Positioning Document of Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) on Tobacco Harm Reduction Strategies]Carlos A Jiménez Ruiz, Segismundo Solano-Reina, Eva de Higes-Martínez, et al.
Journal of Clinical Medicine|October 31, 2020
Similar Clinical Course and Significance of Circulating Innate and Adaptive Immune Cell Counts in STEMI and COVID-19Elena de Dios, Cesar Rios-Navarro, Nerea Perez-Sole, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 23, 2025
Brief Report: Emphysema as a Prognostic Factor in Patients With Advanced NSCLC With COPD Receiving Immune Checkpoint InhibitorsMadeleine Di Frisco, Miguel F Sanmamed, José María Ferrández, et al.
Archivos De Bronconeumologia|December 27, 2016
Guidelines for the Treatment of Smoking in Hospitalized PatientsCarlos A Jiménez Ruiz, Jose Ignacio de Granda Orive, Segismundo Solano Reina, et al.
JMIR Research Protocols|January 23, 2026
Efficacy, Safety, and Economic Impact of Cytisinicline Maintenance Therapy in Patients Who Are Candidates for Smoking Cessation: Protocol for a Phase IV, Multicenter, Randomized, Open-Label, Controlled, Parallel Clinical Trial (CITISILONG Trial)Carlos Rabade Castedo, Ana Estany-Gestal, Carlos A Jiménez Ruiz, et al.
Respiratory Research|September 12, 2022
Lung function and radiological findings 1 year after COVID-19: a prospective follow-upJulia Tarraso, Belen Safont, Juan A Carbonell-Asins, et al.
Archivos De Bronconeumologia|September 9, 2021
Lung Function, Radiological Findings and Biomarkers of Fibrogenesis in a Cohort of COVID-19 Patients Six Months After Hospital DischargeBelen Safont, Julia Tarraso, Enrique Rodriguez-Borja, et al.
Open Respiratory Archives|December 24, 2025
Predictors of Progression in Pre-COPD: The 3P Study Rationale and DesignCruz González-Villaescusa, Julia Tarrasó Castillo, Dolores Martínez-Pitarch, et al.
Journal of Clinical Medicine|January 21, 2023
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)Ivan J Núñez-Gil, Gisela Feltes, María C Viana-Llamas, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
American Journal of Respiratory Cell and Molecular Biology|February 27, 2023
Biomarkers of Fibrosis in Patients with COVID-19 One Year After Hospital Discharge: A Prospective Cohort StudyAlba Mulet, Julia Tarrasó, Enrique Rodríguez-Borja, et al.
Open Respiratory Archives|July 27, 2023
[Positioning Document of Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) on Tobacco Harm Reduction Strategies]Carlos A Jiménez Ruiz, Segismundo Solano-Reina, Eva de Higes-Martínez, et al.
Journal of Clinical Medicine|October 31, 2020
Similar Clinical Course and Significance of Circulating Innate and Adaptive Immune Cell Counts in STEMI and COVID-19Elena de Dios, Cesar Rios-Navarro, Nerea Perez-Sole, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 23, 2025
Brief Report: Emphysema as a Prognostic Factor in Patients With Advanced NSCLC With COPD Receiving Immune Checkpoint InhibitorsMadeleine Di Frisco, Miguel F Sanmamed, José María Ferrández, et al.
Archivos De Bronconeumologia|December 27, 2016
Guidelines for the Treatment of Smoking in Hospitalized PatientsCarlos A Jiménez Ruiz, Jose Ignacio de Granda Orive, Segismundo Solano Reina, et al.
JMIR Research Protocols|January 23, 2026
Efficacy, Safety, and Economic Impact of Cytisinicline Maintenance Therapy in Patients Who Are Candidates for Smoking Cessation: Protocol for a Phase IV, Multicenter, Randomized, Open-Label, Controlled, Parallel Clinical Trial (CITISILONG Trial)Carlos Rabade Castedo, Ana Estany-Gestal, Carlos A Jiménez Ruiz, et al.
Respiratory Research|September 12, 2022
Lung function and radiological findings 1 year after COVID-19: a prospective follow-upJulia Tarraso, Belen Safont, Juan A Carbonell-Asins, et al.
Archivos De Bronconeumologia|September 9, 2021
Lung Function, Radiological Findings and Biomarkers of Fibrogenesis in a Cohort of COVID-19 Patients Six Months After Hospital DischargeBelen Safont, Julia Tarraso, Enrique Rodriguez-Borja, et al.
Open Respiratory Archives|December 24, 2025
Predictors of Progression in Pre-COPD: The 3P Study Rationale and DesignCruz González-Villaescusa, Julia Tarrasó Castillo, Dolores Martínez-Pitarch, et al.
Journal of Clinical Medicine|January 21, 2023
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)Ivan J Núñez-Gil, Gisela Feltes, María C Viana-Llamas, et al.
Pageof 8